Health Condition 1: N949- Unspecified condition associated with female genital organs and menstrual cycle
Conditions
Interventions
Intervention1: Safuf Phali-e-Babul (Acacia arabica pods powder): Dosage Form: Powder in Capsule Form
Dose: 4 Capsules (500 mg each) orally twice daily (BD)
Composition: Powder of Acacia Arabica unseed
Sponsors
National Research Institute Of Unani Medicine For Skin Disorders
Eligibility
Inclusion criteria
Inclusion criteria: i) Female patients in the age group of 13-45 years ii) Patients of Sayal ?n al-Ra?im (Leucorrhoea) having the following symptoms: a) Excessive white or creamy vaginal discharge evident from persistent vulvar moistness or staining of the undergarments (brownish-yellow stain on drying) or need to wear a vulvar pad, with or without any of the following associated symptoms: b) Waja‘ al-Kh ??ira (Low Backache) c) ?u’f-i-‘Am (General Weakness) d) Non-infective Leucorrhoea
Exclusion criteria
Exclusion criteria: i) Age below 13 years and above 45 years ii) Patients with Pelvic Inflammatory Disease (PID), Infective leucorrhea iii) Positive History of Venereal Disease/ Sexually Transmitted Disease (Syphilis, Gonorrhoea) iv) Patients using oral contraceptive pills (OCPs), intrauterine contraceptive device (IUCD), hormone therapy, and any long-term medications v) Significant Pulmonary/Cardiovascular/Hepato-Renal Dysfunction vi) Known cases of Immunocompromised states (HIV/ AIDS, etc.)/ Malignancies vii) Post-delivery or post-abortion period of viii) Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Discharge per vaginum from baseline after treatment of 6 weeks Timepoint: 42 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| i) Relief in Low Backache ii) Improvement in symptoms of generalized weakness iii) Systemic Safety assessmentTimepoint: 42 Days | — |
Countries
India
Contacts
Public ContactDr Alfiya Inayat Ansari
National Research Institute Of Unani Medicine For Skin Disorders
Outcome results
None listed